Brief: Biovica International Says Observational Trial With Divitum TKa Started
April 12 (Reuters) - Biovica International AB
BIOVICb.ST :
* OBSERVATIONAL TRIAL WITH DIVITUM TKA STARTED AT MAYO
CLINIC,
FLORIDA TO VALIDATE UTILITY OF DIVITUM TKA AS AN EFFECTIVE TOOL
FOR DISEASE MONITORING
Further company coverage: BIOVICb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))